FTC sues major pharmacy benefit supervisors above insulin charges The agency introduced motion in opposition to Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the listing price of life-conserving insulin medications. Previously this summer season, the company held prolonged negotiations with Steward about https://rylantlbri.mdkblog.com/36354262/not-known-factual-statements-about-healthcare-news